The authors discuss changes that occurred after three PPIs were removed from a hospital formulary and one less expensive, preferred PPI was added.
You are here
P&T® Journal contents for December 2006
Formulary Substitution of Proton Pump Inhibitors Based on Acquisition Price: Changes in Usage and Costs of Acid-Suppressant Therapies
The authors review approaches for attention-deficit/hyperactivity disorder, mood disorders, bipolar disorder, mania, acute agitation, tic disorder or Tourette syndrome, binge-eating disorders, and the risk of suicidal behavior.
Standard and novel agents for various hematological malignancies include therapies for Hodgkinâ€™s lymphoma, chronic lymphocytic leukemia, acute and chronic myelogenous leukemia, myelodysplastic syndromes, and multiple myeloma.
COLD-fX, which differs from generic ginseng, affects both innate and acquired immune responses. The results of pivotal clinical trials are discussed.
Continuing Education Credit
For many years, attention-deficit/hyperactivity disorder was thought to affect only children and adolescents. The authors describe ADHD in adults and review the efficacy of the drugs prescribed for this population.